Atalaya Capital Management LP - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 53 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Atalaya Capital Management LP ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$5,115,000
+1.4%
500,0000.0%1.63%
+80.6%
Q4 2022$5,045,000
+2.3%
500,0000.0%0.90%
+35.0%
Q3 2022$4,930,000
+1.2%
500,0000.0%0.67%
+16.3%
Q2 2022$4,870,000
-0.2%
500,0000.0%0.58%
+10.8%
Q1 2022$4,880,000
-0.7%
500,0000.0%0.52%
+7.7%
Q4 2021$4,915,0000.0%500,0000.0%0.48%
-35.8%
Q3 2021$4,915,000500,0000.75%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q3 2022
NameSharesValueWeighting ↓
683 Capital Management, LLC 1,199,000$11,672,0000.82%
MMCAP International Inc. SPC 800,000$7,788,0000.62%
Arena Capital Advisors, LLC- CA 250,917$2,443,0000.62%
Atalaya Capital Management LP 500,000$4,870,0000.58%
DG Capital Management, LLC 127,665$1,243,0000.45%
Kepos Capital LP 500,000$4,868,0000.44%
KIM, LLC 800,000$7,792,0000.37%
ANGELO GORDON & CO., L.P. 300,000$2,921,0000.32%
FIR TREE CAPITAL MANAGEMENT LP 950,803$9,261,0000.29%
P SCHOENFELD ASSET MANAGEMENT LP 500,000$4,868,0000.28%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders